111, Inc. (YI)
| Market Cap | 48.19M -26.0% |
| Revenue (ttm) | 1.80B -12.8% |
| Net Income | -9.49M |
| EPS | -1.09 |
| Shares Out | 8.67M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 460 |
| Open | 5.56 |
| Previous Close | 5.71 |
| Day's Range | 5.56 - 5.56 |
| 52-Week Range | 2.48 - 11.17 |
| Beta | 0.66 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jun 18, 2026 |
About YI
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutica... [Read more]
Financial Performance
In 2025, 111, Inc.'s revenue was 12.56 billion, a decrease of -12.81% compared to the previous year's 14.40 billion. Losses were -66.39 million, 2.55% more than in 2024.
Financial numbers in CNY Financial StatementsNews
111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results
Continuing Transition to an Asset-Light Business Model to Improve Overall Efficiency Delivered Non-GAAP Operating Profitability in Both Q4'25 and FY'25 Generated Positive Operating Cash Flow for Both ...
111, Inc. Announces Third Quarter 2025 Unaudited Financial Results
Transition from An Asset-Heavy Business Model to An Asset-Light Business Model Achieved Quarterly Non-GAAP Net Profitability Maintained Non-GAAP Operational Profitability for Three Consecutive Quarter...
111, Inc. Announces Second Quarter 2025 Unaudited Financial Results
Maintained Quarterly Operational Profitability Operating Expenses as a Percentage of Revenues Decreased 20 Basis Points YoY Maintained Positive Operating Cash Flow in the First Half of the Year SHANGH...
111, Inc. Announces First Quarter 2025 Unaudited Financial Results
Maintained Quarterly Operational Profitability Operating Expenses as a Percentage of Revenues Decreased 30 Basis Points YoY Maintained Quarterly Positive Operating Cash Flow SHANGHAI , June 19, 2025 /...
111, Inc. Transcript: Status Update
Despite a 4% revenue decline in 2024 due to sector headwinds, operational profit and positive cash flow were achieved through cost control and AI-driven efficiency. The company plans to expand its fulfillment network, deepen AI integration, and maintain profitability in 2025.
111, Inc. Earnings Call Transcript: Q4 2024
Delivered first-ever annual operating profit and positive cash flow in 2024, driven by cost control, digital transformation, and AI integration, despite macroeconomic and regulatory headwinds. Expanded fulfillment network and achieved significant efficiency gains.
111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Achieved First-Ever Annual Operating Profit Bottom Line Improved by RMB332.7 Million YoY in 2024 Operating Expenses as a Percentage of Revenues Decreased 230 Basis Points YoY in 2024 Q4'24 Operating E...
111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025
SHANGHAI , March 12, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indus...
111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow
SHANGHAI , Feb. 20, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111, Inc. Regains Compliance with NASDAQ Requirement
SHANGHAI , Feb. 11, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indus...
Compound Semiconductor Market to surpass USD 111.6 billion by 2032, Says Global Market Insights inc.
Compound Semiconductor Industry size is expected to register 10.9% CAGR between 2024 and 2032 propelled by electric vehicles and renewable energy. Compound Semiconductor Industry size is expected to r...
111, Inc. Announces ADS Ratio Change
SHANGHAI , Jan. 8, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industr...
111, Inc. Transcript: Fireside Chat
Profitability and positive cash flow have been sustained for three quarters amid industry headwinds. Strategic innovation in fulfillment and digital operations is driving efficiency, while demographic trends support long-term growth. Compliance and market valuation issues are being addressed.
111, Inc. Earnings Call Transcript: Q3 2024
Operational profitability was maintained for the third consecutive quarter, with flat revenue but a 10.5% increase in gross profit and significant reductions in operating expenses. Digital transformation and supply chain enhancements drove efficiency, positioning the company for long-term growth.
111, Inc. Announces Third Quarter 2024 Unaudited Financial Results
Maintained Operational Profitability for the Third Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoY Held Positive Operating Cash Flow for Three Consecu...
111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024
SHANGHAI , Nov. 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 - Conference Call to Follow
SHANGHAI , Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industr...
111, Inc. Announces Change to Board of Directors
SHANGHAI , Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industr...
111, Inc. Transcript: Status Update
Fragmentation and lack of digitization challenge China's pharma supply chain, but advanced proprietary systems and a flexible fulfillment network have driven efficiency and cost reductions. Expansion plans include at least five new centers, supporting growth beyond RMB 20 billion revenue.
111, Inc. to Participate in Fireside Chat with Water Tower Research on October 30, 2024
SHANGHAI , Oct. 22, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow
SHANGHAI , Oct. 18, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111 Inc. Expands National Supply Chain Network with New Fulfillment Centers across South and Central China
SHANGHAI , Oct. 10, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indust...
111, Inc. Announces Receipt of Notification from Nasdaq
SHANGHAI , Sept. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indus...
Synthetic Fiber Market Size is Anticipated to Reach USD 111.9 billion, Advancing at a CAGR of 4.8% by 2034: Transparency Market Research Inc.
Surge in demand for synthetic fibers in the medical sector for manufacturing surgical garments, wound dressings, and medical textiles. Surge in demand for synthetic fibers in the medical sector for ma...
111 Inc. Announces Its Co-founders' Strategic Share Purchase and Highlights Continued Growth and Innovation
SHANGHAI , Sept. 13, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indus...